{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:25:05Z","timestamp":1777595105287,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00115-018-0562-9","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T05:53:20Z","timestamp":1530683600000},"page":"148-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kongenitale myasthene Syndrome im Erwachsenenalter","Congenital myasthenic syndromes in adulthood"],"prefix":"10.1007","volume":"90","author":[{"given":"G.","family":"Wunderlich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Abicht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Brunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-S.","family":"Daimag\u00fcler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schroeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. R.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. C.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cirak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"562_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1055\/s-0037-1602832","volume":"48","author":"G McMacken","year":"2017","unstructured":"McMacken G, Abicht A, Evangelista T et\u00a0al (2017) The increasing genetic and phenotypical diversity of congenital myasthenic syndromes. Neuropediatrics 48:294\u2013308","journal-title":"Neuropediatrics"},{"key":"562_CR2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.nmd.2005.05.001","volume":"15","author":"D Beeson","year":"2005","unstructured":"Beeson D, Hanta\u00ef D, Lochm\u00fcller H et\u00a0al (2005) 126th International Workshop: congenital myasthenic syndromes, 24\u201326 September 2004, Naarden, the Netherlands. Neuromuscul Disord 15:498\u2013512","journal-title":"Neuromuscul Disord"},{"key":"562_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399407000427","volume":"9","author":"JS M\u00fcller","year":"2007","unstructured":"M\u00fcller JS, Mihaylova V, Abicht A et\u00a0al (2007) Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission. Expert Rev Mol Med 9:1\u201320","journal-title":"Expert Rev Mol Med"},{"key":"562_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","volume":"14","author":"AG Engel","year":"2015","unstructured":"Engel AG, Shen XM, Selcen D et\u00a0al (2015) Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol 14:420\u2013434","journal-title":"Lancet Neurol"},{"key":"562_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","volume":"64","author":"SJ Wood","year":"2001","unstructured":"Wood SJ, Slater CR (2001) Safety factor at the neuromuscular junction. Prog Neurobiol 64:393\u2013429","journal-title":"Prog Neurobiol"},{"key":"562_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0072-9752(07)01502-3","volume":"91","author":"CR Slater","year":"2008","unstructured":"Slater CR (2008) Reliability of neuromuscular transmission and how it is maintained. Handb Clin Neurol 91:27\u2013101","journal-title":"Handb Clin Neurol"},{"key":"562_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1101\/SQB.1990.055.01.041","volume":"55","author":"UJ McMahan","year":"1990","unstructured":"McMahan UJ (1990) The agrin hypothesis. Cold Spring Harb Symp Quant Biol 55:407\u2013418","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"562_CR8","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1242\/dev.02696","volume":"133","author":"SD Weatherbee","year":"2006","unstructured":"Weatherbee SD, Anderson KV, Niswander LA (2006) LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 133:4993\u20135000","journal-title":"Development"},{"key":"562_CR9","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1074\/jbc.273.11.6467","volume":"273","author":"C Hopf","year":"1998","unstructured":"Hopf C, Hoch W (1998) Dimerization of the muscle-specific kinase induces tyrosine phosphorylation of acetylcholine receptors and their aggregation on the surface of myotubes. J\u00a0Biol Chem 273:6467\u20136473","journal-title":"J Biol Chem"},{"key":"562_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/35097557","volume":"2","author":"JR Sanes","year":"2001","unstructured":"Sanes JR, Lichtman JW (2001) Induction, assembly, maturation and maintenance of a\u00a0postsynaptic apparatus. Nat Rev Neurosci 2:791\u2013805","journal-title":"Nat Rev Neurosci"},{"key":"562_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev.neuro.26.041002.131412","volume":"27","author":"TC Sudhof","year":"2004","unstructured":"Sudhof TC (2004) The synaptic vesicle cycle. Annu Rev Neurosci 27:509\u2013547","journal-title":"Annu Rev Neurosci"},{"key":"562_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1749-6632.1987.tb27203.x","volume":"493","author":"SM Parsons","year":"1987","unstructured":"Parsons SM, Bahr BA, Gracz LM et\u00a0al (1987) Acetylcholine transport: fundamental properties and effects of pharmacologic agents. Ann N Y Acad Sci 493:220\u2013233","journal-title":"Ann N Y Acad Sci"},{"key":"562_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0079-6123(08)62090-7","volume":"109","author":"H Varoqui","year":"1996","unstructured":"Varoqui H, Meunier FM, Meunier FA et\u00a0al (1996) Expression of the vesicular acetylcholine transporter in mammalian cells. Prog Brain Res 109:83\u201395","journal-title":"Prog Brain Res"},{"issue":"175","key":"562_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/3-540-29784-7_21","volume":"2006","author":"MH Bazalakova","year":"2006","unstructured":"Bazalakova MH, Blakely RD (2006) The high-affinity choline transporter: a\u00a0critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. Handb Exp Pharmacol 2006(175):525\u2013544","journal-title":"Handb Exp Pharmacol"},{"key":"562_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1152\/physrev.00033.2014","volume":"95","author":"LA Tintignac","year":"2015","unstructured":"Tintignac LA, Brenner HR, R\u00fcegg MA (2015) Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting. Physiol Rev 95:809\u2013852","journal-title":"Physiol Rev"},{"key":"562_CR16","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1093\/hmg\/ddn305","volume":"17","author":"A Masuda","year":"2008","unstructured":"Masuda A, Shen XM, Ito M et\u00a0al (2008) hnRNP H enhances skipping of a\u00a0nonfunctional exon P3A in CHRNA1 and a\u00a0mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet 17:4022\u20134035","journal-title":"Hum Mol Genet"},{"key":"562_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ajhg.2013.05.009","volume":"93","author":"KJ Carss","year":"2013","unstructured":"Carss KJ, Stevens E, Foley AR et al (2013) Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of \u03b1\u2011dystroglycan. Am J Hum Genet 93:29\u201341","journal-title":"Am J Hum Genet"},{"key":"562_CR18","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/brain\/awv185","volume":"138","author":"K Belaya","year":"2015","unstructured":"Belaya K, Rodr\u00edguez CPM, Liu WW et\u00a0al (2015) Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies. Brain 138:2493\u20132504","journal-title":"Brain"},{"key":"562_CR19","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1212\/WNL.53.7.1564","volume":"53","author":"A Abicht","year":"1999","unstructured":"Abicht A, Stucka R, Karcagi V et\u00a0al (1999) A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin. Neurology 53:1564\u20131569","journal-title":"Neurology"},{"key":"562_CR20","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.3233\/JND-150098","volume":"2","author":"T Evangelista","year":"2015","unstructured":"Evangelista T, Hanna M, Lochm\u00fcller H (2015) Congenital myasthenic syndromes with predominant limb girdle weakness. J\u00a0Neuromuscul Dis 2:S21\u2013S29","journal-title":"J Neuromuscul Dis"},{"key":"562_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ana.410110603","volume":"11","author":"AG Engel","year":"1982","unstructured":"Engel AG, Lambert EH, Mulder DM et al (1982) A newly recognized congenital myasthenic syndrome attributed to a\u00a0prolonged open time of the acetylcholine-induced ion channel. Ann Neurol 11:553\u2013569","journal-title":"Ann Neurol"},{"key":"562_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/jnnp-2016-313163","volume":"87","author":"PM Rodr\u00edguez Cruz","year":"2016","unstructured":"Rodr\u00edguez Cruz PM, Belaya K, Basiri K et\u00a0al (2016) Clinical features of the myasthenic syndrome arising from mutations in GMPPB. J\u00a0Neurol Neurosurg Psychiatr 87:802\u2013809","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"562_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/mus.25035","volume":"54","author":"S Finlayson","year":"2016","unstructured":"Finlayson S, Morrow JM, Rodriguez CPM et\u00a0al (2016) Muscle magnetic resonance imaging in congenital myasthenic syndromes. Muscle Nerve 54:211\u2013219","journal-title":"Muscle Nerve"},{"key":"562_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/ana.21408","volume":"64","author":"D Selcen","year":"2008","unstructured":"Selcen D, Milone M, Shen XM et al (2008) Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients. Ann Neurol 64:71\u201387","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"562_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/brain\/116.3.633","volume":"116","author":"DO Hutchinson","year":"1993","unstructured":"Hutchinson DO, Walls TJ, Nakano S et\u00a0al (1993) Congenital endplate acetylcholinesterase deficiency. Brain 116(Pt 3):633\u2013653","journal-title":"Brain"},{"key":"562_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajhg.2012.05.022","volume":"91","author":"K Belaya","year":"2012","unstructured":"Belaya K, Finlayson S, Slater CR et al (2012) Mutations in DPAGT1 cause a\u00a0limb-girdle congenital myasthenic syndrome with tubular aggregates. Am J Hum Genet 91:193\u2013201","journal-title":"Am J Hum Genet"},{"key":"562_CR27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s00415-011-6262-z","volume":"259","author":"V Guergueltcheva","year":"2012","unstructured":"Guergueltcheva V, M\u00fcller JS, Dusl M et\u00a0al (2012) Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations. J\u00a0Neurol 259:838\u2013850","journal-title":"J Neurol"},{"key":"562_CR28","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1212\/WNL.0000000000002185","volume":"85","author":"RG Whittaker","year":"2015","unstructured":"Whittaker RG, Herrmann DN, Bansagi B et\u00a0al (2015) Electrophysiologic features of SYT2 mutations causing a\u00a0treatable neuromuscular syndrome. Neurology 85:1964\u20131971","journal-title":"Neurology"},{"key":"562_CR29","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1212\/NXG.0000000000000105","volume":"2","author":"AG Engel","year":"2016","unstructured":"Engel AG, Selcen D, Shen XM et al (2016) Loss of MUNC13-1 function causes microcephaly, cortical hyperexcitability, and fatal myasthenia. Neurol Genet 2:e105","journal-title":"Neurol Genet"},{"key":"562_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/acn3.387","volume":"4","author":"XM Shen","year":"2017","unstructured":"Shen XM, Scola RH, Lorenzoni PJ et al (2017) Novel synaptobrevin-1 mutation causes fatal congenital myasthenic syndrome. Ann Clin Transl Neurol 4:130\u2013138","journal-title":"Ann Clin Transl Neurol"},{"key":"562_CR31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1001\/jama.1957.02970480021005","volume":"163","author":"LM Eaton","year":"1957","unstructured":"Eaton LM, Lambert EH (1957) Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J\u00a0Am Med Assoc 163:1117\u20131124","journal-title":"J Am Med Assoc"},{"key":"562_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S0960-8966(01)00336-4","volume":"12","author":"RF Byring","year":"2002","unstructured":"Byring RF, Pihko H, Tsujino A et\u00a0al (2002) Congenital myasthenic syndrome associated with episodic apnea and sudden infant death. Neuromuscul Disord 12:548\u2013553","journal-title":"Neuromuscul Disord"},{"key":"562_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/WNL.37.2.206","volume":"37","author":"M Mora","year":"1987","unstructured":"Mora M, Lambert EH, Engel AG (1987) Synaptic vesicle abnormality in familial infantile myasthenia. Neurology 37:206\u2013214","journal-title":"Neurology"},{"key":"562_CR34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1127::AID-MUS7>3.0.CO;2-1","volume":"19","author":"JG Dijk van","year":"1996","unstructured":"van Dijk JG, Lammers GJ, Wintzen AR et\u00a0al (1996) Repetitive CMAPs: mechanisms of neural and synaptic genesis. Muscle Nerve 19:1127\u20131133","journal-title":"Muscle Nerve"},{"key":"562_CR35","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/mus.880170720","volume":"17","author":"MB Bromberg","year":"1994","unstructured":"Bromberg MB, Scott DM (1994) Single fiber EMG reference values: reformatted in tabular form. AD HOC Committee of the AAEM Single Fiber Special Interest Group. Muscle Nerve 17:820\u2013821","journal-title":"Muscle Nerve"},{"key":"562_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ana.10077","volume":"51","author":"CM Gomez","year":"2002","unstructured":"Gomez CM, Maselli RA, Vohra BP et al (2002) Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms. Ann Neurol 51:102\u2013112","journal-title":"Ann Neurol"},{"key":"562_CR37","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/humu.23043","volume":"37","author":"XM Shen","year":"2016","unstructured":"Shen XM, Okuno T, Milone M et al (2016) Mutations causing slow-channel myasthenia reveal that a\u00a0valine ring in the channel pore of muscle AChR is optimized for stabilizing channel gating. Hum Mutat 37:1051\u20131059","journal-title":"Hum Mutat"},{"key":"562_CR38","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1152\/physrev.00015.2011","volume":"92","author":"SM Sine","year":"2012","unstructured":"Sine SM (2012) End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease. Physiol Rev 92:1189\u20131234","journal-title":"Physiol Rev"},{"key":"562_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nmd.2013.10.009","volume":"24","author":"R Webster","year":"2014","unstructured":"Webster R, Liu WW, Chaouch A et al (2014) Fast-channel congenital myasthenic syndrome with a\u00a0novel acetylcholine receptor mutation at the \u03b1\u2011\u03b5 subunit interface. Neuromuscul Disord 24:143\u2013147","journal-title":"Neuromuscul Disord"},{"key":"562_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00415-011-6204-9","volume":"259","author":"A Chaouch","year":"2012","unstructured":"Chaouch A, M\u00fcller JS, Guergueltcheva V et al (2012) A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. J\u00a0Neurol 259:474\u2013481","journal-title":"J Neurol"},{"key":"562_CR41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/brain\/awm325","volume":"131","author":"V Mihaylova","year":"2008","unstructured":"Mihaylova V, M\u00fcller JS, Vilchez JJ et al (2008) Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes. Brain 131:747\u2013759","journal-title":"Brain"},{"key":"562_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1212\/WNL.58.4.603","volume":"58","author":"YA Shapira","year":"2002","unstructured":"Shapira YA, Sadeh ME, Bergtraum MP et\u00a0al (2002) Three novel COLQ mutations and variation of phenotypic expressivity due to G240X. Neurology 58:603\u2013609","journal-title":"Neurology"},{"key":"562_CR43","first-page":"25","volume":"27","author":"Y Yamanashi","year":"2008","unstructured":"Yamanashi Y, Higuch O, Beeson D (2008) Dok-7\/MuSK signaling and a\u00a0congenital myasthenic syndrome. Acta Myol 27:25\u201329","journal-title":"Acta Myol"},{"key":"562_CR44","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s00415-015-7963-5","volume":"263","author":"S Binks","year":"2016","unstructured":"Binks S, Vincent A, Palace J (2016) Myasthenia gravis: a\u00a0clinical-immunological update. J\u00a0Neurol 263:826\u2013834","journal-title":"J Neurol"},{"key":"562_CR45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.nurt.2008.07.003","volume":"5","author":"U Schara","year":"2008","unstructured":"Schara U, Lochm\u00fcller H (2008) Therapeutic strategies in congenital myasthenic syndromes. Neurotherapeutics 5:542\u2013547","journal-title":"Neurotherapeutics"},{"key":"562_CR46","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0006-3495(78)85503-9","volume":"22","author":"GE Kirsch","year":"1978","unstructured":"Kirsch GE, Narahashi T (1978) 3,4-diaminopyridine. A potent new potassium channel blocker. Biophys\u00a0J 22:507\u2013512","journal-title":"Biophys J"},{"key":"562_CR47","first-page":"341","volume":"7","author":"S Lindquist","year":"2011","unstructured":"Lindquist S, Stangel M (2011) Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine. Neuropsychiatr Dis Treat 7:341\u2013349","journal-title":"Neuropsychiatr Dis Treat"},{"key":"562_CR48","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/brain\/awl200","volume":"129","author":"CR Slater","year":"2006","unstructured":"Slater CR, Fawcett PR, Walls TJ et al (2006) Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a\u00a0group of patients with \u201alimb-girdle myasthenia\u2018. Brain 129:2061\u20132076","journal-title":"Brain"},{"key":"562_CR49","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1097\/00001756-199806010-00044","volume":"9","author":"T Fukudome","year":"1998","unstructured":"Fukudome T, Ohno K, Brengman JM et al (1998) Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. Neuroreport 9:1907\u20131911","journal-title":"Neuroreport"},{"key":"562_CR50","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1212\/01.WNL.0000061483.11417.1B","volume":"60","author":"CM Harper","year":"2003","unstructured":"Harper CM, Fukodome T, Engel AG (2003) Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology 60:1710\u20131713","journal-title":"Neurology"},{"key":"562_CR51","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","volume":"4","author":"AG Engel","year":"2007","unstructured":"Engel AG (2007) The therapy of congenital myasthenic syndromes. Neurotherapeutics 4:252\u2013257","journal-title":"Neurotherapeutics"},{"key":"562_CR52","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/ana.410430411","volume":"43","author":"CM Harper","year":"1998","unstructured":"Harper CM, Engel AG (1998) Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. Ann Neurol 43:480\u2013484","journal-title":"Ann Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-018-0562-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0562-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0562-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T23:15:33Z","timestamp":1562195733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-018-0562-9"}},"subtitle":["Diagnostisch herausfordernd, selten, aber behandelbar","Challenging, rare but treatable"],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1007\/s00115-018-0562-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"4 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"G.\u00a0Wunderlich, A.\u00a0Abicht, A.\u00a0Brunn, H.-S.\u00a0Daimag\u00fcler, M.\u00a0Schroeter, G.\u00a0R.\u00a0Fink, H.\u00a0C.\u00a0Lehmann und S.\u00a0Cirak geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}